Portfolio Overview – Nov 2019
The Fund returned +3.80% net of fees for the month of November 2019. The portfolio’s largest positive contributions for the month came from long positions in Xero, Cochlear and CSL while largest detractors were short positions in Virgin Money UK plc, Caltex Australia and a long position in National Australia Bank. The Fund had 30 long positions and 19 short positions with largest exposure to medical devices & services and technology stocks. There was relatively less exposure in the financial services and materials stocks.